ATE397013T1 - Kohlenhydrat-vernetzte glykoproteinkristalle - Google Patents

Kohlenhydrat-vernetzte glykoproteinkristalle

Info

Publication number
ATE397013T1
ATE397013T1 AT98939254T AT98939254T ATE397013T1 AT E397013 T1 ATE397013 T1 AT E397013T1 AT 98939254 T AT98939254 T AT 98939254T AT 98939254 T AT98939254 T AT 98939254T AT E397013 T1 ATE397013 T1 AT E397013T1
Authority
AT
Austria
Prior art keywords
linked glycoprotein
glycoprotein crystals
carbohydrate cross
carbohydrate
cross
Prior art date
Application number
AT98939254T
Other languages
English (en)
Inventor
Alexey Margolin
Chandrika Govardham
Kalevi Visuri
Sinikka Uotila
Original Assignee
Altus Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Altus Pharmaceuticals Inc filed Critical Altus Pharmaceuticals Inc
Application granted granted Critical
Publication of ATE397013T1 publication Critical patent/ATE397013T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N11/00—Carrier-bound or immobilised enzymes; Carrier-bound or immobilised microbial cells; Preparation thereof
    • C12N11/02—Enzymes or microbial cells immobilised on or in an organic carrier
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/21—Retroviridae, e.g. equine infectious anemia virus
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2/00—Peptides of undefined number of amino acids; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K9/00—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/96—Stabilising an enzyme by forming an adduct or a composition; Forming enzyme conjugates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/64—Medicinal preparations containing antigens or antibodies characterised by the architecture of the carrier-antigen complex, e.g. repetition of carrier-antigen units
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2299/00—Coordinates from 3D structures of peptides, e.g. proteins or enzymes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16111—Human Immunodeficiency Virus, HIV concerning HIV env
    • C12N2740/16134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/81—Carrier - bound or immobilized peptides or proteins and the preparation thereof, e.g. biological cell or cell fragment as carrier
    • Y10S530/812—Peptides or proteins is immobilized on, or in, an organic carrier
    • Y10S530/813—Carrier is a saccharide
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/81—Carrier - bound or immobilized peptides or proteins and the preparation thereof, e.g. biological cell or cell fragment as carrier
    • Y10S530/812—Peptides or proteins is immobilized on, or in, an organic carrier
    • Y10S530/815—Carrier is a synthetic polymer
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/81—Carrier - bound or immobilized peptides or proteins and the preparation thereof, e.g. biological cell or cell fragment as carrier
    • Y10S530/812—Peptides or proteins is immobilized on, or in, an organic carrier
    • Y10S530/815—Carrier is a synthetic polymer
    • Y10S530/816—Attached to the carrier via a bridging agent

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Biophysics (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Mycology (AREA)
  • Public Health (AREA)
  • Virology (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Communicable Diseases (AREA)
  • Hematology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
AT98939254T 1997-09-05 1998-08-06 Kohlenhydrat-vernetzte glykoproteinkristalle ATE397013T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US92627997A 1997-09-05 1997-09-05

Publications (1)

Publication Number Publication Date
ATE397013T1 true ATE397013T1 (de) 2008-06-15

Family

ID=25452985

Family Applications (1)

Application Number Title Priority Date Filing Date
AT98939254T ATE397013T1 (de) 1997-09-05 1998-08-06 Kohlenhydrat-vernetzte glykoproteinkristalle

Country Status (11)

Country Link
US (2) US6359118B2 (de)
EP (2) EP1009759B1 (de)
AR (1) AR017066A1 (de)
AT (1) ATE397013T1 (de)
AU (1) AU8772498A (de)
DE (1) DE69839563D1 (de)
DK (1) DK1009759T3 (de)
ES (1) ES2306477T3 (de)
PE (1) PE130399A1 (de)
WO (1) WO1999012959A1 (de)
ZA (1) ZA987378B (de)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69839563D1 (de) * 1997-09-05 2008-07-10 Altus Pharmaceuticals Inc Kohlenhydrat-vernetzte glykoproteinkristalle
US6500933B1 (en) 1997-09-05 2002-12-31 Altus Biologics Inc. Methods of preparing carbohydrate crosslinked glycoprotein crystals
WO2002036070A2 (en) * 2000-10-30 2002-05-10 Wayne State University Novel fish chemokine and methods for use
KR100902966B1 (ko) * 2000-10-30 2009-06-15 마이크로소프트 코포레이션 비교를 위해 스트링을 맵핑하는 방법 및 시스템
EP1333087A1 (de) * 2002-02-05 2003-08-06 Avantium International B.V. Vernetzte Enzymaggregaten und Vernetzer dafür
EP1549675B1 (de) * 2002-08-31 2008-02-13 CJ Corp Glycosylierte humane interferon alpha isoform
FR2848847B1 (fr) * 2002-12-18 2005-10-14 Coletica Composition cosmetique ou dermopharmaceutique comprenant une enzyme insoluble en milieu aqueux, ainsi que ses utilisations
AU2003300126B2 (en) * 2002-12-31 2010-04-01 Altus Pharmaceuticals Inc. Complexes of protein crystals and ionic polymers
CA2512052C (en) 2002-12-31 2016-06-21 Altus Pharmaceuticals Inc. Human growth hormone crystals and methods for preparing them
EP1699921B1 (de) * 2004-01-01 2009-11-04 Council of Scientific and Industrial Research;an Indian Reg. body incorporated under Reg. of Societies Act (Act XXI of 1860) Methode zur herstellung von quervernetzten protein kristallen
RU2385736C2 (ru) 2004-10-14 2010-04-10 Элтус Фармасьютикалз Инк. Композиции, содержащие липазу, протеазу и амилазу, предназначенные для лечения недостаточности поджелудочной железы
US8835143B2 (en) 2004-10-28 2014-09-16 Clea Technologies Bv Method for preparing hybrid cross-linked enzyme-silica aggregates
NL1027360C2 (nl) * 2004-10-28 2006-05-01 Clea Technologies B V Werkwijze voor de bereiding van vernette enzymaggregaten met verbeterde eigenschappen.
US20090023629A1 (en) * 2005-12-23 2009-01-22 Altus Pharmaceuticals Inc. Compositions comprising polycation-complexed protein crystals and methods of treatment using them
EP3438131B1 (de) 2006-02-10 2022-03-16 Life Technologies Corporation Modifizierung von oligosacchariden und etikettierung von proteinen
WO2009023731A1 (en) * 2007-08-13 2009-02-19 Sunrez Corporation Compositions for neutralization and decontamination of toxic chemical and biological agents
WO2011107990A1 (en) * 2010-03-02 2011-09-09 Protalix Ltd. Stabilized alpha-galactosidase and uses thereof
CN104704359A (zh) 2012-10-25 2015-06-10 生命科技公司 糖蛋白酶介导位点特异性放射性标记的方法和组合物
WO2014089578A1 (en) * 2012-12-07 2014-06-12 Cornell University Crosslinked thermoset resins and methods thereof
CN110095485B (zh) * 2018-01-29 2024-01-30 中国科学院上海有机化学研究所 一种蛋白质微小晶体冷冻样品的制备及结构解析的方法
AU2022254851A1 (en) 2021-04-09 2023-11-23 Cilian Ag Purification of proteins

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4713249A (en) 1981-11-12 1987-12-15 Schroeder Ulf Crystallized carbohydrate matrix for biologically active substances, a process of preparing said matrix, and the use thereof
CA1196864A (en) 1983-06-10 1985-11-19 Mattheus F.A. Goosen Controlled release of injectable and implantable insulin compositions
AT381463B (de) 1984-03-09 1986-10-27 Sleytr Uwe B Definierte poren aufweisende membran, verfahren zu ihrer herstellung und verwendung derselben
FI85285C (fi) 1988-05-13 1992-03-25 Stabra Ag Tvaerbundet, vattenoloesligt glukosisomeras och foerfarande foer framstaellning daerav.
US5066490A (en) 1988-06-01 1991-11-19 The United States Of America As Represented By The Secretary Of The Department Of Health & Human Services Protein crosslinking reagents cleavable within acidified intracellular vesicles
GB2225324B (en) * 1988-11-25 1993-02-03 Branko Kozulic Stabilization of glycoproteins
US5270194A (en) 1989-08-31 1993-12-14 Instrumentation Laboratory Spa Stabilized glucose oxidase from Aspergillus Niger
US5120650A (en) 1989-10-13 1992-06-09 Stabra Ag Method for producing crystalline glucose isomerase
US5443841A (en) 1992-06-15 1995-08-22 Emisphere Technologies, Inc. Proteinoid microspheres and methods for preparation and use thereof
US5801022A (en) 1990-08-03 1998-09-01 Vertex Pharmaceuticals, Incorporated Method of producing a product with crosslinked crystals of thermolysin
US5618710A (en) * 1990-08-03 1997-04-08 Vertex Pharmaceuticals, Inc. Crosslinked enzyme crystals
HUT65904A (en) * 1990-08-03 1994-07-28 Vertex Pharma Method for immobilization of enzyme in the form of crosslinked crystals
CA2064683A1 (en) * 1992-03-26 1993-09-27 Krishna Mohan Rao Kallury Formation of thermostable enzymes with extra-ordinary heat tolerance by immobilization on phospholipid matrices
SE9302278D0 (sv) 1992-10-28 1993-07-02 Kabi Pharmacia Ab Growth hormone
US5827531A (en) 1994-12-02 1998-10-27 The United States Of America As Represented By The Administrator Of The National Aeronautics And Space Administration Microcapsules and methods for making
US6004549A (en) 1994-12-14 1999-12-21 Schering Corporation Crystalline protein controlled release compositions
US5811406A (en) 1995-06-07 1998-09-22 Regents Of The University Of California Dry powder formulations of polynucleotide complexes
US5932212A (en) * 1996-05-24 1999-08-03 Altus Biologics, Inc. Crosslinked protein crystal formulations and their use as catalysts in organic solvents
AU4738197A (en) 1996-09-24 1998-04-17 Altus Biologics Inc. Crosslinked protein crystals as universal separation media
BR9808285A (pt) 1997-03-20 2000-05-16 Novo Nordisk As Cristais de insulina isentos de zinco, formulação terapêutica em pó, processo para a preparação de cristais de insulina isentos de zinco, uso de cristais isentos de zinco, e, processo para o tratamento de diabetes mellitus
US6140475A (en) 1997-04-11 2000-10-31 Altus Biologics Inc. Controlled dissolution crosslinked protein crystals
DE69839563D1 (de) * 1997-09-05 2008-07-10 Altus Pharmaceuticals Inc Kohlenhydrat-vernetzte glykoproteinkristalle

Also Published As

Publication number Publication date
EP1956085A2 (de) 2008-08-13
AR017066A1 (es) 2001-08-22
ES2306477T3 (es) 2008-11-01
US20010008934A1 (en) 2001-07-19
PE130399A1 (es) 1999-12-22
EP1009759A1 (de) 2000-06-21
US20020137899A1 (en) 2002-09-26
AU8772498A (en) 1999-03-29
ZA987378B (en) 2000-02-17
DK1009759T3 (da) 2008-08-04
WO1999012959A1 (en) 1999-03-18
EP1009759B1 (de) 2008-05-28
DE69839563D1 (de) 2008-07-10
US6359118B2 (en) 2002-03-19

Similar Documents

Publication Publication Date Title
ATE397013T1 (de) Kohlenhydrat-vernetzte glykoproteinkristalle
NO20003081D0 (no) Glykagonlignende peptid-1-krystaller
DE69821928D1 (de) Intrakardiales defibrillierungssystem
DE59706054D1 (de) Elektrochromes system
BR9705960A (pt) Módulo de função
ATE239030T1 (de) Kohlenhydrat-derivate
NO983809D0 (no) Vekselretter
NO983805D0 (no) Vekselretter
DE69604968T2 (de) Wagenblockierkeil
DE69823908D1 (de) Einkristallziehvorrichtung
NO970910D0 (no) Spirostanylglykosidal-krystaller
NO976130D0 (no) Modul-transportörsystem
DE29716010U1 (de) Nachtschutzbrille
DE69832233D1 (de) Vibrations-Drehsensor
DE69828563D1 (de) Glasscheibe
DE29721975U1 (de) Montageelement
DE29720981U1 (de) Blendschutzsystem
IT241875Y1 (it) Struttura di occhiali
ATA151097A (de) Spiegelanlage
DE29614257U1 (de) Lateralelement
DE29718999U1 (de) Montageelement
ID26178A (id) N-alkenil heteroarililoksiasetamida pembasmi hama atau gulma
DE29708781U1 (de) Funktionsmodul
DE29723475U1 (de) Funktionsmodul
DE29605620U1 (de) Sicherungselement

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties